Skip to main content
Clinical Trials/KCT0006329
KCT0006329
Completed
未知

Human study to evaluate the efficacy and safety of Dendropanax morbiferus leaves extract on cognitive function improvement

Ewha Womens University0 sites85 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Mental and behavioural disorders
Sponsor
Ewha Womens University
Enrollment
85
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 26, 2022
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Ewha Womens University

Eligibility Criteria

Inclusion Criteria

  • 1\) Who agrees to participate in this study and signs a written agreement
  • 2\) Adult aged 50 to under 80
  • 3\) Who complains of subjective cognitive decline

Exclusion Criteria

  • 1\) Who is suspected of having dementia as a result of a neuropsychological examination
  • 2\) Who is diagnosed with any axis 1 psychiatric disorders
  • 3\) Who has suicidal ideation
  • 4\) Who has resistant Hypertension, uncontrolled diabetes, malignancy, severe cerebrovascular disease, heart disease, neuropsychological disease, traumatic brain damage accompanied by loss of consciousness or convulsions, acute stroke, severe hearing and vision impairment
  • 5\) Who has taken medications and health functional foods that may affect cognitive and memory function
  • 6\) Any contraindications to MRI
  • 7\) Who is diagnosed with an intellectual disability or less than a high school graduate
  • 8\) Participants in other clinical studies
  • 9\) Pregnant women or lactating women or persons who have plans for pregnancy
  • 10\) Who has hypersensitivity to ingredients contained in the experimental and placebo foods or has experienced severe food allergy reactions

Outcomes

Primary Outcomes

Not specified

Similar Trials